| Stage | BCC | % of rev | APOG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.8B | 100.00% | $391M | 100.00% | BCC ×4.61 |
| Gross profit | $296M | 16.40% | $96M | 24.59% | APOG +8.2pp |
| Operating income | $56M | 3.10% | $33M | 8.56% | APOG +5.5pp |
| Pre-tax income | $51M | 2.82% | $30M | 7.78% | APOG +5.0pp |
| Net income | $36M | 2.02% | $22M | 5.72% | APOG +3.7pp |
| Stage | BCC | APOG | Gap · A − B |
|---|---|---|---|
| Revenue | $1.8B100.00% | $391M100.00% | BCC ×4.61 |
| Gross profit | 16.40%$296M | 24.59%$96M | APOG +8.2pp |
| Operating income | 3.10%$56M | 8.56%$33M | APOG +5.5pp |
| Pre-tax income | 2.82%$51M | 7.78%$30M | APOG +5.0pp |
| Net income |
| 2.02%$36M |
| 5.72%$22M |
| APOG +3.7pp |
No disclosed counterparties: APOG.
None